| Gail Ann Mills, PT | |
|
702 Platinum Dr, Cody, WY 82414-3420 | |
| (307) 578-7883 | |
| (307) 586-2350 |
| Full Name | Gail Ann Mills |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 702 Platinum Dr, Cody, Wyoming |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316312960 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 0187 (Wyoming) | Primary |
| Provider Name | North Platte Physical Therapy Services Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1093914111 PECOS PAC ID: 8921080565 Enrollment ID: O20040607000307 |
News Archive
The emerging Zika virus is a particular threat to pregnant women. The disease can be transmitted by the bite of an infected mosquito and is associated with devastating birth defects, like microcephaly. No approved vaccine against the virus exists.
The symptoms and side effects of Covid-19 are scattered across a diagnostic spectrum. Some patients are asymptomatic or experience a mild immune response, while others report significant long-term illnesses, lasting complications, or suffer fatal outcomes.
Cancer Research UK and Cancer Research Technology the charity's development and commercialisation arm together with immatics biotechnologies have launched the first clinical trial of a promising cancer vaccine to treat glioblastoma, one of the most common forms of brain cancer.
Advaxis, Inc., a leader in developing cancer immunotherapies, announced today that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration Office of Orphan Products Development (OOPD) for ADXS-HPV, its lead immunotherapy drug candidate, for the treatment of Stage II-IV invasive cervical cancer.
› Verified 9 days ago
| Provider Name | Big Country Rehabilitation Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1366493264 PECOS PAC ID: 0648253666 Enrollment ID: O20040610001233 |
News Archive
The emerging Zika virus is a particular threat to pregnant women. The disease can be transmitted by the bite of an infected mosquito and is associated with devastating birth defects, like microcephaly. No approved vaccine against the virus exists.
The symptoms and side effects of Covid-19 are scattered across a diagnostic spectrum. Some patients are asymptomatic or experience a mild immune response, while others report significant long-term illnesses, lasting complications, or suffer fatal outcomes.
Cancer Research UK and Cancer Research Technology the charity's development and commercialisation arm together with immatics biotechnologies have launched the first clinical trial of a promising cancer vaccine to treat glioblastoma, one of the most common forms of brain cancer.
Advaxis, Inc., a leader in developing cancer immunotherapies, announced today that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration Office of Orphan Products Development (OOPD) for ADXS-HPV, its lead immunotherapy drug candidate, for the treatment of Stage II-IV invasive cervical cancer.
› Verified 9 days ago
| Provider Name | Bear Lodge Rehabilitation Services, Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1558690099 PECOS PAC ID: 7911041199 Enrollment ID: O20100225000900 |
News Archive
The emerging Zika virus is a particular threat to pregnant women. The disease can be transmitted by the bite of an infected mosquito and is associated with devastating birth defects, like microcephaly. No approved vaccine against the virus exists.
The symptoms and side effects of Covid-19 are scattered across a diagnostic spectrum. Some patients are asymptomatic or experience a mild immune response, while others report significant long-term illnesses, lasting complications, or suffer fatal outcomes.
Cancer Research UK and Cancer Research Technology the charity's development and commercialisation arm together with immatics biotechnologies have launched the first clinical trial of a promising cancer vaccine to treat glioblastoma, one of the most common forms of brain cancer.
Advaxis, Inc., a leader in developing cancer immunotherapies, announced today that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration Office of Orphan Products Development (OOPD) for ADXS-HPV, its lead immunotherapy drug candidate, for the treatment of Stage II-IV invasive cervical cancer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gail Ann Mills, PT Po Box 1790, Douglas, WY 82633-1790 Ph: (307) 358-9464 | Gail Ann Mills, PT 702 Platinum Dr, Cody, WY 82414-3420 Ph: (307) 578-7883 |
News Archive
The emerging Zika virus is a particular threat to pregnant women. The disease can be transmitted by the bite of an infected mosquito and is associated with devastating birth defects, like microcephaly. No approved vaccine against the virus exists.
The symptoms and side effects of Covid-19 are scattered across a diagnostic spectrum. Some patients are asymptomatic or experience a mild immune response, while others report significant long-term illnesses, lasting complications, or suffer fatal outcomes.
Cancer Research UK and Cancer Research Technology the charity's development and commercialisation arm together with immatics biotechnologies have launched the first clinical trial of a promising cancer vaccine to treat glioblastoma, one of the most common forms of brain cancer.
Advaxis, Inc., a leader in developing cancer immunotherapies, announced today that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration Office of Orphan Products Development (OOPD) for ADXS-HPV, its lead immunotherapy drug candidate, for the treatment of Stage II-IV invasive cervical cancer.
› Verified 9 days ago
Nia Marie Torres, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2456 Carter Ave, Cody, WY 82414 Phone: 575-779-5895 | |
Kristen Michelle Goldberg, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 544 Yellowstone Ave, Cody, WY 82414 Phone: 307-587-9789 Fax: 307-587-9787 | |
Lori Grubbs Swanton, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1130 Sheridan Ave Ste 210, Cody, WY 82414 Phone: 307-213-9595 Fax: 307-939-2249 | |
Timothy P Stecker, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 720 Lindsay Ln, Cody, WY 82414 Phone: 307-578-1970 Fax: 307-578-1973 | |
Lacy Martin, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 544 Yellowstone Ave, Cody, WY 82414 Phone: 307-587-9789 Fax: 307-587-9787 | |
Adam K Johnnidis, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 720 Lindsay Ln, Cody, WY 82414 Phone: 307-578-1970 |